Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions

被引：26

作者：

Hayashi, T ^{[1
]}

Nishioka, J ^{[1
]}

Kamada, H ^{[1
]}

Asanuma, K ^{[1
]}

Kondo, H ^{[1
]}

Gabazza, EC ^{[1
]}

Ido, M ^{[1
]}

Suzuki, K ^{[1
]}

机构：

[1] Mie Univ, Sch Med, Dept Mol Pathobiol, Tsu, Mie 5148507, Japan

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2004年 / 2卷 / 06期

关键词：

activated protein C; inflammation; protein C; inhibitor; tissue expression; transgenic mice;

D O I：

10.1111/j.1538-7836.2004.00733.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In humans, protein C inhibitor (PCI) is expressed in various tissues and present in many body fluids including plasma and seminal fluid. In rodents, PCI is expressed in reproductive organs only and is absent in plasma. In this study, we characterized the tissue expression and physiological role of PCI in novel human PCI gene transgenic (TG) mice. Northern blot and immunohistochemical analyses demonstrated that human PCI is expressed in liver hepatocytes, renal epithelial cells as well as heart, brain and reproductive organs of the TG mice. This PCI tissue distribution is similar to that found in humans. PCI in plasma of TG mice showed the same immunological and functional properties Lis human plasma PCI. Next, we evaluated the effect of PCI on coagulation, inflammation and tissue damage in lipopolysaccharide-treated TG mice. The results suggested that PCI efficiently inhibits not only the anticoagulant and anti-inflammatory activities of exogenously injected human activated protein C (APC) but also that of endogenously produced APC in mice with endotoxemia. These findings suggest that PCI exerts a procoagulant and proinflammatory effect by inhibiting APC. We believe our results also show how useful these TG mice may be for assessing the therapeutic effect of human APC in vivo and for evaluating the role of PCI in human physiological and pathological conditions.

引用

页码：949 / 961

页数：13

共 53 条

[1]

Aoki Y, 2000, ARZNEIMITTELFORSCH, V50, P809

[2] Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].

Bernard, GR ;

Vincent, JL ;

Laterre, P ;

LaRosa, SP ;

Dhainaut, JF ;

Lopez-Rodriguez, A ;

Steingrub, JS ;

Garber, GE ;

Helterbrand, JD ;

Ely, EW ;

Fisher, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709

[3] MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].

BERTINA, RM ;

KOELEMAN, BPC ;

KOSTER, T ;

ROSENDAAL, FR ;

DIRVEN, RJ ;

DERONDE, H ;

VANDERVELDEN, PA ;

REITSMA, PH .

NATURE, 1994, 369 (6475) :64-67

[4]

CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2

[5] RECOVERY FROM HEMOPHILIA-B LEYDEN - AN ANDROGEN-RESPONSIVE ELEMENT IN THE FACTOR-IX PROMOTER [J].

CROSSLEY, M ;

LUDWIG, M ;

STOWELL, KM ;

DEVOS, P ;

OLEK, K ;

BROWNLEE, GG .

SCIENCE, 1992, 257 (5068) :377-379

[6]

EAPANA F, 1991, BLOOD, V77, P1754

[7] Protein C inhibitor may modulate human sperm-oocyte interactions [J].

Elisen, MGLM ;

van Kooij, RJ ;

Nolte, MA ;

Marquart, JA ;

Lock, TMTWT ;

Bouma, BN ;

Meijers, JCM .

BIOLOGY OF REPRODUCTION, 1998, 58 (03) :670-677

[8] FUNCTIONALLY ACTIVE PROTEIN-C INHIBITOR PLASMINOGEN-ACTIVATOR INHIBITOR-3 (PCI/PAI-3) IS SECRETED IN SEMINAL-VESICLES, OCCURS AT HIGH-CONCENTRATIONS IN HUMAN SEMINAL PLASMA AND COMPLEXES WITH PROSTATE-SPECIFIC ANTIGEN [J].

ESPANA, F ;

GILABERT, J ;

ESTELLES, A ;

ROMEU, A ;

AZNAR, J ;

CABO, A .

THROMBOSIS RESEARCH, 1991, 64 (03) :309-320

[9]

ESPANA F, 1993, THROMB HAEMOSTASIS, V70, P989

[10]

FRANCIS RB, 1984, THROMB HAEMOSTASIS, V52, P71

← 1 2 3 4 5 6 →